Update on Update on Pharmacotherapies for PTSDPharmacotherapies for PTSD
Michelle Pent, MD, MPHMichelle Pent, MD, MPH
April 29, 2011April 29, 2011
PresentationPresentation
• Anxiety-spectrum disorder
• DSM-IV criteria– A: Exposure to traumatic event with perceive
threat to life or physical integrity and response of intense fear
– B: Re-experience of the traumatic event– C: Avoidance of stimuli associated with the
trauma– D: Hyperarousal
Target SymptomsTarget Symptoms
• Intrusive ruminations
• Nightmares
• Flashbacks
• Hyperarousal
• Hypervigilance
• Associated irritability, anger, poor focus and concentration, and physiologic distress
NeurochemistryNeurochemistry
• Amygdala
• Central Nervous System– Norepinephrine, Serotonin, Dopamine, GABA
• Peripheral Nervous System– Sympathetic Nervous System– “Fight or flight”
TreatmentTreatment
• Psychotherapy
• Pharmacotherapy
• Most evidence suggests psychotherapy is most effective– CBT– EMDR– DBT where indicated
Complimentary TreatmentsComplimentary Treatments
• Yoga/Meditation
• Acupuncture
• Mindfulness Training
• Relaxation Therapy
PharmacotherapyPharmacotherapy
• Objective is to improve symptoms by minimizing anxiety– Selective Serotonin Reuptake Inhibitors– Other antidepressants– Anxiolytics– Other
Selective Serotonin Reuptake Selective Serotonin Reuptake Inhibitors (SSRIs)Inhibitors (SSRIs)
• Raise serotonin levels in the brain
• Remain standard of care for anxiety disorders
• Linked with– Improvement in baseline level of anxiety– Diminished intrusive ruminations
SSRIsSSRIs
• Fluoxetine (Prozac)
• Sertraline (Zoloft)
• Fluvoxamine (Luvox)
• Paroxetine (Paxil)
• Citalopram (Celexa)
• Escitalopram (Lexapro)
SSRIsSSRIs
• Lag time before efficacy– Usually 4-6 weeks– Adequate trial a minimum of 8 weeks
• Side effects– Nausea, diarrhea– Weight gain– Agitation– Sexual dysfunction
Other AntidepressantsOther Antidepressants
• Selective Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)– Venlafaxine (Effexor)– Duloxetine (Cymbalta)– Desvenlafaxine (Pristiq)
• Tricyclic Antidepressants– Amitryptyline (Elavil)– Doxepin (Sinequan)
AnxiolyticsAnxiolytics
• Benzodiazepines
• Alpha adrenergic antagonists
• Buspirone
• Antihistamines
BenzodiazepinesBenzodiazepines
• Diminish anxiety by enhancing GABA in the central nervous system
• No longitudinal effect on anxiety• Significant tolerance and dependence
– Essentially contraindicated in patients with history of substance abuse
• Intended for short term use• Increasingly considered inappropriate for
long term treatment of anxiety disorders
BenzodiazepinesBenzodiazepines
• Diazepam (Valium)
• Lorazepam (Ativan)
• Alprazolam (Xanax)
• Clonazepam (Klonopin)
• Oxazepam (Serax)
• Chlordiazepoxide (Librium)
• Temazepam (Restoril)
Other AnxiolyticsOther Anxiolytics
• Buspirone (Buspar)– Serotonin agent– May cause headache, nausea
• Antihistamines– Diphenhydramine (Benadryl)– Hydroxyzine (Vistaril)– Side effects include sedation, confusion at
high doses
Other AnxiolyticsOther Anxiolytics
• Alpha adrenergic antagonists– Blood pressure medications– Prazosin (Minipress)– Clonidine (Catapres)– Side effects include dizziness and other
complications of low blood pressure
Other AnxiolyticsOther Anxiolytics
• Gabapentin– Anticonvulsant/Mood Stabilizer– Enhances GABA in central nervous system– Some usefulness for anxiety– Limited addictive potential
Use of AntipsychoticsUse of Antipsychotics
• May be useful as anxiolytics
• Use does not necessarily imply psychosis
• Significant sedation, weight gain, metabolic disturbance
• Most commonly used– Quetiapine (Seroquel)– Olanzapine (Zyprexa)– Ziprasidone (Geodon)
SleepSleep
• Benzodiazepine analogues– Eszopiclone (Lunesta)– Zolpidem (Ambien)– Addictive potential
• Benzodiazepines– Short term use
SleepSleep
• Trazodone (Desyrel)– Often exacerbates nightmares
• Mirtazapine (Remeron)– Associated with weight gain
• Melatonin– Ramelteon (Rozerem)